Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/04/20
End: 02/24/25
Due: 02/24/26
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 10/01/25
End: 06/30/28
Due: 06/30/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients | NCT04369846 | Xantho Biotechnology Co., LTD | user2@example.com | None | 2020-05-04 | 2025-02-24 | 2026-02-24 | - | - | 2025-07-14 |
| A Study of GM-XANTHO in Pressure Ulcer Patients | NCT05199077 | Xantho Biotechnology Co., LTD | user2@example.com | None | 2025-07-01 | 2028-04-30 | 2029-04-30 | - | - | 2025-07-14 |
| A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis | NCT06620692 | Xantho Biotechnology Co., LTD | user2@example.com | None | 2025-10-01 | 2028-06-30 | 2029-06-30 | - | - | 2025-07-14 |